TEM vs UNH

Tempus AI Inc. continues to be viewed as a strong contender in the AI-driven precision medicine space. Based on the previous analysis (Q4 2025 earnings), the company demonstrated robust revenue growth (83% YoY) and critically achieved positive adjusted EBITDA, signaling a clear path towards profitability and mitigating a key risk. Strategic partnerships and a proprietary multi-modal data library p...

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...